206 related articles for article (PubMed ID: 3941399)
1. Effects of nimodipine on cerebral blood flow in conscious rat.
Kanda K; Flaim SF
J Pharmacol Exp Ther; 1986 Jan; 236(1):41-7. PubMed ID: 3941399
[TBL] [Abstract][Full Text] [Related]
2. Effects of nimodipine on cerebral blood flow.
Haws CW; Gourley JK; Heistad DD
J Pharmacol Exp Ther; 1983 Apr; 225(1):24-8. PubMed ID: 6834275
[TBL] [Abstract][Full Text] [Related]
3. Effect of vasodilating drugs on intracortical and extracortical vascular resistance following middle cerebral artery occlusion in cats.
Date H; Hossmann KA
Ann Neurol; 1984 Sep; 16(3):330-6. PubMed ID: 6385825
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular profile of RWJ 29009, a new potassium channel activator, in anesthetized and conscious dogs.
Damiano BP; Giardino EC; Haertlein BJ; Stump GL; Mitchell JA; Falotico R
J Cardiovasc Pharmacol; 1994 Feb; 23(2):300-10. PubMed ID: 7511761
[TBL] [Abstract][Full Text] [Related]
5. Acute effects of nimodipine on the cerebral blood flow and intracranial pressure.
Gaab MR; Haubitz I; Brawanski A; Korn A; Czech T
Neurochirurgia (Stuttg); 1985 May; 28 Suppl 1():93-9. PubMed ID: 4010872
[TBL] [Abstract][Full Text] [Related]
6. Microcirculatory actions and uses of naturally-occurring (magnesium) and novel synthetic calcium channel blockers.
Altura BM; Altura BT
Microcirc Endothelium Lymphatics; 1984 Apr; 1(2):185-220. PubMed ID: 6400430
[TBL] [Abstract][Full Text] [Related]
7. [Effect of kavinton on systemic and regional hemodynamics in waking and anesthetized rats].
Ivashev MN; Martynova ER; Medvedev OS
Farmakol Toksikol; 1989; 52(1):26-9. PubMed ID: 2707414
[TBL] [Abstract][Full Text] [Related]
8. Effects of diltiazem on total cardiac output distribution in conscious rats.
Flaim SF; Zelis R
J Pharmacol Exp Ther; 1982 Aug; 222(2):359-66. PubMed ID: 7097556
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular actions of the dihydropyridine calcium antagonist nimodipine in the dog.
Satoh K; Kawada M; Wada Y; Taira N
Arzneimittelforschung; 1984; 34(5):563-8. PubMed ID: 6540573
[TBL] [Abstract][Full Text] [Related]
10. Effects of nisoldipine on cardiocirculatory dynamics and cardiac output distribution in conscious rats at rest and during treadmill exercise.
Drexler H; Flaim SF; Fields RH; Zelis R
J Pharmacol Exp Ther; 1985 Feb; 232(2):376-81. PubMed ID: 3968639
[TBL] [Abstract][Full Text] [Related]
11. In vivo actions of a calcium channel blocker (nimodipine) on the cerebrovascular response to infused 5-hydroxytryptamine.
McCalden TA; Tanahashi N; Nath RG; Coleman L; Meyer JS
J Pharmacol Exp Ther; 1986 Apr; 237(1):36-9. PubMed ID: 3958972
[TBL] [Abstract][Full Text] [Related]
12. [Nimodipine and experimental combined disorders of cerebral and coronary circulation].
Mirzoian RS; Khaĭlov NA; Tsorin IB; Gan'shina TS
Eksp Klin Farmakol; 2009; 72(2):24-8. PubMed ID: 19441723
[TBL] [Abstract][Full Text] [Related]
13. Regional vascular effects of MPC-1304, a novel dihydropyridine derivative, in conscious normotensive and spontaneously hypertensive rats.
Miyoshi K; Kanda A; Nozawa Y; Nakano M; Miyake H
J Pharmacol Exp Ther; 1996 Jun; 277(3):1328-36. PubMed ID: 8667194
[TBL] [Abstract][Full Text] [Related]
14. Effects of cerebroprotective agents on cerebral blood flow and on postischemic energy metabolism in the rat brain.
Bielenberg GW; Beck T; Sauer D; Burniol M; Krieglstein J
J Cereb Blood Flow Metab; 1987 Aug; 7(4):480-8. PubMed ID: 3611206
[TBL] [Abstract][Full Text] [Related]
15. [Hemodynamic effects of the new calcium antagonist nimodipine in normal and increased blood pressure].
Engberding R; Bender F; Gülker H; Specker E; Molinski M
Z Kardiol; 1984 Aug; 73(8):498-503. PubMed ID: 6495809
[TBL] [Abstract][Full Text] [Related]
16. Effects of the novel coronary selective calcium channel blocker, McN-6186, on cardiocirculatory dynamics, coronary vascular resistance, and cardiac output distribution in normal, conscious rats.
Flaim SF; Stranieri MT; Gill A; Carson JR; Brannan MD
J Cardiovasc Pharmacol; 1990 May; 15(5):780-90. PubMed ID: 1692939
[TBL] [Abstract][Full Text] [Related]
17. Effect of the calcium antagonist nimodipine on the delayed hypoperfusion following incomplete ischemia in the rat.
Smith ML; Kågström E; Rosén I; Siesjö BK
J Cereb Blood Flow Metab; 1983 Dec; 3(4):543-6. PubMed ID: 6630325
[TBL] [Abstract][Full Text] [Related]
18. [Comparative study of dilceren (nimodipine) on the cerebral circulation in the intact animals and animals subjected to ischemic brain damage].
Aleksandrin VV; Khaĭlov NA; Mirzoian GR; Gan'shina TS
Eksp Klin Farmakol; 2002; 65(2):17-9. PubMed ID: 12109284
[TBL] [Abstract][Full Text] [Related]
19. [Effects of verticillatine on cerebral blood flow, cerebral vascular resistance and blood pressure in anesthetized dogs and cats].
Zeng GY; Tian BH; Zhou R; Du LF; Xu C
Zhongguo Yao Li Xue Bao; 1991 Sep; 12(5):471-4. PubMed ID: 1687908
[TBL] [Abstract][Full Text] [Related]
20. Effect of the newly synthetized calcium antagonist isopropyl methyl 2-carbamoyloxymethyl-6-methyl-4-(2,3-dichlorophenyl)-1,4-dihydropyridine-3,5- dicarboxylate on cerebral venous outflow in dogs.
Nishikibe M; Kamei K; Nagura J; Suzuki K
Arzneimittelforschung; 1989 Jun; 39(6):678-81. PubMed ID: 2775334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
